三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > 表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠
图片属性
图片格式：PNG 图片大小：94KB 图片尺寸：2362*430
同报告图片
 / 4
表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠_第1页
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
表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠_第2页
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
表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠_第3页
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
表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠_第4页
表8.卡度尼利单抗用于治疗1L肝细胞癌的OS率或优于阿替利珠及帕博利珠_第5页
所属报告： 康方生物-港股公司研究报告-深耕双抗领域核心资产逐步释放潜力-230609（27页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠